CRISPR Therapeutics AGCRSPNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher.
Left:
||||
Free cash flow yield
Latest
-4.36%
Near historical average
Average (9y)
-4.46%
Historical baseline
Range
High:14.12%
Low:-23.49%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -4.36% | +19.9% |
| 2023 | -5.44% | +67.7% |
| 2022 | -16.86% | -312.2% |
| 2021 | 7.95% | +412.5% |
| 2020 | -2.54% | -268.5% |
| 2019 | 1.51% | +120.9% |
| 2018 | -7.23% | +12.9% |
| 2017 | -8.30% | +64.7% |
| 2016 | -23.49% | -266.4% |
| 2015 | 14.12% | - |